Inhalerx Share Price and Company Fundamentals



Price
$0.061
Change
-0.003 (-4.688%)
52 week
0.052 - 0.13

Last traded: Today at 4:34 AM

InhaleRx Limited focuses on developing inhalation medicinal therapies in Australia and internationally. It offers medical inhalation devices for the delivery of prescribed medicines. Its solutions include Medihale inhaler, a sealed pod inhaler for use with inhaled medicinal cannabinoid formulations. The company was formerly known as Lifespot Health Ltd and changed its name to InhaleRx Limited in October 2021. InhaleRx Limited was incorporated in 2016 and is based in Sydney, Australia.

Key Metrics

PE ratio

-

PB ratio

6.65

Dividend yield

0.00%

Beta

-0.15

Market cap

-

Enterprise value

-

Company profile

Primary activitiesDevelopment of telemedicine, mobile applications
Industry / SectorMedical Devices / Healthcare
Websitehttps://inhalerx.com.au
Mailing address126 Phillip Street Level 5 Sydney NSW 2000 Australia
Phone / Fax61 2 8072 1400 / 61 3 8678 1747
Share registryAUTOMIC REGISTRY SERVICES

Dividends

More: Inhalerx Dividend history, yield and payout ratio

Dividend yield

0.00%

Dividend amount

$0.00

Payout ratio

0.00%

Inhalerx paid $0.00 dividend and the ex-dividend date was .The dividend payout ratio is 0.00%. The dividend payout ratio is defined as the amout of dividend paid divided by the earnings of the company.IRX dividend payout ratio is less than 70. This is ideal as it gives company room to grow the dividends and also the excess earnings can be invested in company for growth.

IRX's forward dividend amount is $ and the forward dividend yield is . A forward dividend yield is the percentage of a company's current stock price that it expects to pay out as dividends over a certain time period, generally 12 months. Forward dividend yields are generally used in circumstances where the yield is predictable based on past instances. If not, trailing yields, which indicate the same value over the previous 12 months, are used.

Company Executives

As of Oct 2022, following are the company executives and directors listed on Inhalerx.

NameTitleAgeTotal Pay
Mr. Darryl DaviesChief Exec. Officer23.46k
Dr. Robert Jenny Ph.D.Chief Scientific Officer
Mr. Srinivasa Rao SuryadevaraExec. VP53
Ms. Nova Anne TaylorCompany Sec.
Ms. Elizabeth SpoonerJoint Company Sec.

Profitability and management effectiveness

Profit margin

0.00%

Operating margin

-835.03%

Return on assets

-32.39%

Return on equity

-60.59%

Profitability ratios are a class of financial metrics that are used to assess a business's ability to generate earnings relative to its revenue, operating costs, balance sheet assets, and shareholders' equity over time, using data from a specific point in time.

The return on equity signifies how well the management is running the company in terms of capital management. The ideal return on equity is greater than 10%. The return on equity is calculated as net income divided by total share holders equity.

Valuation and Trading Info

The market capitalization of Inhalerx is and its enterprise value is .

Companies similar to Inhalerx (IRX)

Inhalerx (ASX:IRX) Frequently Asked Questions

1. What is Inhalerx's Stock Symbol?

Inhalerx trades on ASX under the ticker symbol "IRX".

2. What is Inhalerx's stock price today?

One share of IRX stock can currently be purchased for approximately $0.061.

3. How can I contact Inhalerx?

Inhalerx's mailing address is 126 Phillip Street Level 5 Sydney NSW 2000 Australia. The company can be reached via phone at 61 2 8072 1400.

4. What is Inhalerx's official website?

The official website of Inhalerx is https://inhalerx.com.au.

5. Which share registry manages Inhalerx's stock?

Inhalerx's stock is managed by AUTOMIC REGISTRY SERVICES.